Finding a way out: lymphocyte egress from lymphoid organs (original) (raw)

• Gowans, J.L. The lymphocyte—a disgraceful gap in medical knowledge. Immunol. Today 17, 288–291 (1996).
  CAS PubMed Google Scholar
• von Andrian, U.H. & Mempel, T.R. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3, 867–878 (2003).
  Article CAS PubMed Google Scholar
• Cyster, J.G. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23, 127–159 (2005).
  CAS PubMed Google Scholar
• Chaffin, K.E. & Perlmutter, R.M. A pertussis toxin-sensitive process controls thymocyte emigration. Eur. J. Immunol. 21, 2565–2573 (1991).
  CAS PubMed Google Scholar
• Adachi, K. et al. Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppressant, FTY720. Bioorg. Med. Chem. Lett. 5, 853–856 (1995).
  CAS Google Scholar
• Brinkmann, V. & Lynch, K.R. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr. Opin. Immunol. 14, 569–575 (2002).
  CAS PubMed Google Scholar
• Chiba, K. et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 160, 5037–5044 (1998).
  CAS PubMed Google Scholar
• Mandala, S. et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296, 346–349 (2002).
  CAS PubMed Google Scholar
• Zemann, B. et al. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 107, 1454–1458 (2006).
  CAS PubMed Google Scholar
• Kharel, Y. et al. Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J. Biol. Chem. 280, 36865–36872 (2005).
  CAS PubMed Google Scholar
• Brinkmann, V. et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277, 21453–21457 (2002).
  Article CAS PubMed Google Scholar
• Liu, Y. et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106, 951–961 (2000).
  CAS PubMed PubMed Central Google Scholar
• Allende, M.L., Dreier, J.L., Mandala, S. & Proia, R.L. Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J. Biol. Chem. 279, 15396–15401 (2004).
  CAS PubMed Google Scholar
• Matloubian, M. et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427, 355–360 (2004).
  CAS PubMed Google Scholar
• Lo, C.G., Xu, Y., Proia, R.L. & Cyster, J.G. Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit. J. Exp. Med. 201, 291–301 (2005).
  CAS PubMed PubMed Central Google Scholar
• Sanna, M.G. et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J. Biol. Chem. 279, 13839–13848 (2004).
  CAS PubMed Google Scholar
• Forrest, M. et al. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor sub-types. J. Pharmacol. Exp. Ther. 309, 758–768 (2004).
  CAS PubMed Google Scholar
• Rosen, H. & Goetzl, E.J. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5, 560–570 (2005).
  CAS PubMed Google Scholar
• Rosen, H., Sanna, M.G., Cahalan, S.M. & Gonzalez-Cabrera, P.J. Tipping the gatekeeper: S1P regulation of endothelial barrier function. Trends Immunol. 28, 102–107 (2007).
  CAS PubMed Google Scholar
• Wei, S.H. et al. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat. Immunol. 6, 1228–1235 (2005).
  CAS PubMed Google Scholar
• Carlson, C.M. et al. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 442, 299–302 (2006).
  CAS PubMed Google Scholar
• Nombela-Arrieta, C. et al. A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress. J. Exp. Med. 204, 497–510 (2007).
  CAS PubMed PubMed Central Google Scholar
• Ishizaki, H. et al. Defective chemokine-directed lymphocyte migration and development in the absence of Rho guanosine diphosphate-dissociation inhibitors alpha and beta. J. Immunol. 177, 8512–8521 (2006).
  CAS PubMed Google Scholar
• Sakata, D. et al. Impaired T lymphocyte trafficking in mice deficient in an actin-nucleating protein, mDia1. J. Exp. Med. 204, 2031–2038 (2007).
  CAS PubMed PubMed Central Google Scholar
• Lee, M.J. et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279, 1552–1555 (1998).
  CAS PubMed Google Scholar
• Hannun, Y.A., Luberto, C. & Argraves, K.M. Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 40, 4893–4903 (2001).
  CAS PubMed Google Scholar
• Spiegel, S. & Milstien, S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4, 397–407 (2003).
  CAS PubMed Google Scholar
• Saba, J.D. & Hla, T. Point-counterpoint of sphingosine 1-phosphate metabolism. Circ. Res. 94, 724–734 (2004).
  CAS PubMed Google Scholar
• Schwab, S.R. et al. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309, 1735–1739 (2005).
  CAS PubMed Google Scholar
• Pappu, R. et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316, 295–298 (2007).
  CAS PubMed Google Scholar
• Allende, M.L. et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J. Biol. Chem. 279, 52487–52492 (2004).
  CAS PubMed Google Scholar
• Mizugishi, K. et al. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol. 25, 11113–11121 (2005).
  CAS PubMed PubMed Central Google Scholar
• Ito, K. et al. Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes. Biochem. Biophys. Res. Commun. 357, 212–217 (2007).
  CAS PubMed Google Scholar
• Murata, N. et al. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem. J. 352, 809–815 (2000).
  CAS PubMed PubMed Central Google Scholar
• Mitra, P. et al. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc. Natl. Acad. Sci. USA 103, 16394–16399 (2006).
  CAS PubMed PubMed Central Google Scholar
• Kobayashi, N. et al. Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner. J. Lipid Res. 47, 614–621 (2006).
  CAS PubMed Google Scholar
• Kuo, C.T., Veselits, M.L. & Leiden, J.M. LKLF: A transcriptional regulator of single-positive T cell quiescence and survival. Science 277, 1986–1990 (1997).
  CAS PubMed Google Scholar
• Hall, J.G. & Morris, B. The immediate effect of antigens on the cell output of a lymph node. Br. J. Exp. Pathol. 46, 450–454 (1965).
  CAS PubMed PubMed Central Google Scholar
• Shiow, L.R. et al. CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440, 540–544 (2006).
  CAS PubMed Google Scholar
• Feng, C. et al. A potential role for CD69 in thymocyte emigration. Int. Immunol. 14, 535–544 (2002).
  CAS PubMed Google Scholar
• Nakayama, T. et al. The generation of mature, single-positive thymocytes in vivo is dysregulated by CD69 blockade or overexpression. J. Immunol. 168, 87–94 (2002).
  CAS PubMed Google Scholar
• Chu, P. et al. Systematic identification of regulatory proteins critical for T-cell activation. J. Biol. 2, 21 (2003).
  PubMed PubMed Central Google Scholar
• Risso, A. et al. CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression. J. Immunol. 146, 4105–4114 (1991).
  CAS PubMed Google Scholar
• Rosen, H., Alfonso, C., Surh, C.D. & McHeyzer-Williams, M.G. Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonist. Proc. Natl. Acad. Sci. USA 100, 10907–10912 (2003).
  CAS PubMed PubMed Central Google Scholar
• Sprent, J., Miller, J.F. & Mitchell, G.F. Antigen-induced selective recruitment of circulating lymphocytes. Cell. Immunol. 2, 171–181 (1971).
  CAS PubMed Google Scholar
• Hay, J.B., Cahill, R.N. & Trnka, Z. The kinetics of antigen-reactive cells during lymphocyte recruitment. Cell. Immunol. 10, 145–153 (1974).
  CAS PubMed Google Scholar
• Graeler, M. & Goetzl, E.J. Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. FASEB J. 16, 1874–1878 (2002).
  CAS PubMed Google Scholar
• Bai, A., Hu, H., Yeung, M. & Chen, J. Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription. J. Immunol. 178, 7632–7639 (2007).
  CAS PubMed Google Scholar
• Chi, H. & Flavell, R.A. Cutting edge: regulation of T cell trafficking and primary immune responses by sphingosine 1-phosphate receptor 1. J. Immunol. 174, 2485–2488 (2005).
  CAS PubMed Google Scholar
• Graler, M.H., Huang, M.C., Watson, S. & Goetzl, E.J. Immunological effects of transgenic constitutive expression of the type 1 sphingosine 1-phosphate receptor by mouse lymphocytes. J. Immunol. 174, 1997–2003 (2005).
  PubMed Google Scholar
• Kabashima, K. et al. Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism. J. Exp. Med. 203, 2683–2690 (2006).
  CAS PubMed PubMed Central Google Scholar
• Lee, M.J. et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99, 301–312 (1999).
  CAS PubMed Google Scholar
• Sanna, M.G. et al. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat. Chem. Biol. 2, 434–441 (2006).
  CAS PubMed Google Scholar
• Foss, F.W., Jr et al. Synthesis and biological evaluation of γ-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists. Bioorg. Med. Chem. 15, 663–677 (2007).
  CAS PubMed Google Scholar
• Visentin, B. et al. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9, 225–238 (2006).
  CAS PubMed Google Scholar
• Oo, M.L. et al. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J. Biol. Chem. 282, 9082–9089 (2007).
  CAS PubMed Google Scholar
• Gonzalez-Cabrera, P.J., Hla, T. & Rosen, H. Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics. J. Biol. Chem. 282, 7254–7264 (2007).
  CAS PubMed Google Scholar
• Graler, M.H. & Goetzl, E.J. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 18, 551–553 (2004).
  CAS PubMed Google Scholar
• Halin, C. et al. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches. Blood 106, 1314–1322 (2005).
  CAS PubMed PubMed Central Google Scholar
• Pabst, O. et al. Enhanced FTY720-mediated lymphocyte homing requires Gαi signaling and depends on β2 and β7 integrin. J. Immunol. 176, 1474–1480 (2006).
  CAS PubMed Google Scholar
• Cinamon, G. et al. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat. Immunol. 5, 713–720 (2004).
  CAS PubMed Google Scholar
• Cinamon, G., Zachariah, M., Lam, O. & Cyster, J.G. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol. (in the press).
• Walzer, T. et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat. Immunol. 8, 1337–1344 (2007).
  CAS PubMed Google Scholar
• Olivera, A. et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 26, 287–297 (2007).
  CAS PubMed Google Scholar
• Jolly, P.S. et al. Transactivation of sphingosine-1-phosphate receptors by FcɛRI triggering is required for normal mast cell degranulation and chemotaxis. J. Exp. Med. 199, 959–970 (2004).
  CAS PubMed PubMed Central Google Scholar
• Huang, M.C., Watson, S.R., Liao, J.J. & Goetzl, E.J. Th17 augmentation in OTII TCR plus T cell-selective type 1 sphingosine 1-phosphate receptor double transgenic mice. J. Immunol. 178, 6806–6813 (2007).
  CAS PubMed Google Scholar
• Czeloth, N., Bernhardt, G., Hofmann, F., Genth, H. & Forster, R. Sphingosine-1-phosphate mediates migration of mature dendritic cells. J. Immunol. 175, 2960–2967 (2005).
  CAS PubMed Google Scholar
• Idzko, M. et al. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J. Clin. Invest. 116, 2935–2944 (2006).
  CAS PubMed PubMed Central Google Scholar
• Muller, H. et al. The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur. J. Immunol. 35, 533–545 (2005).
  PubMed Google Scholar
• Maeda, Y. et al. Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3. J. Immunol. 178, 3437–3446 (2007).
  CAS PubMed Google Scholar
• Daniel, C. et al. FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells. J. Immunol. 178, 2458–2468 (2007).
  CAS PubMed Google Scholar
• Sawicka, E. et al. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity. J. Immunol. 175, 7973–7980 (2005).
  CAS PubMed Google Scholar
• Kato, S. Thymic microvascular system. Microsc. Res. Tech. 38, 287–299 (1997).
  CAS PubMed Google Scholar
• Ueno, T. et al. Role for CCR7 ligands in the emigration of newly generated T lymphocytes from the neonatal thymus. Immunity 16, 205–218 (2002).
  CAS PubMed Google Scholar
• Hofmann, M., Brinkmann, V. & Zerwes, H.G. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs. Int. Immunopharmacol. 6, 1902–1910 (2006).
  CAS PubMed Google Scholar
• Morris, M.A. et al. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720. Eur. J. Immunol. 35, 3570–3580 (2005).
  CAS PubMed Google Scholar
• Don, A.S. et al. Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues. J. Biol. Chem. 282, 15833–15842 (2007).
  CAS PubMed Google Scholar
• Kunisawa, J. et al. Sphingosine 1-phosphate regulates peritoneal B-cell trafficking for subsequent intestinal IgA production. Blood 109, 3749–3756 (2007).
  CAS PubMed Google Scholar
• Pinschewer, D.D. et al. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J. Immunol. 164, 5761–5770 (2000).
  CAS PubMed Google Scholar
• Han, S. et al. FTY720 suppresses humoral immunity by inhibiting germinal center reaction. Blood 104, 4129–4133 (2004).
  CAS PubMed Google Scholar
• Vora, K.A. et al. Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement. J. Leukoc. Biol. 78, 471–480 (2005).
  CAS PubMed Google Scholar
• Xie, J.H. et al. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells. J. Immunol. 170, 3662–3670 (2003).
  CAS PubMed Google Scholar
• Kappos, L. et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N. Engl. J. Med. 355, 1124–1140 (2006).
  CAS PubMed Google Scholar
• Brinkmann, V. Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol. Ther. 115, 84–105 (2007).
  CAS PubMed Google Scholar
• Ishii, I., Fukushima, N., Ye, X. & Chun, J. Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 73, 321–354 (2004).
  CAS PubMed Google Scholar